William Wierda, MD, PhD from the University of Texas MD Anderson Cancer Center, Houston, TX talks about recent advances in the treatment of chronic lymphocytic leukemia (CLL), presented at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL. New drugs, and new treatment strategies are having an impact on the standard of care in the field of CLL, and clinicians are now faced with a variety of treatment options that need to be tailored for each patient.